Ipsen announced the signature of an agreement to acquire OctreoPharm Sciences, a private German life sciences company developing innovative radioactive-labeled compounds for molecular imaging diagnostics and therapeutic applications. Ipsen plans to maintain the company location and staff to ensure successful transition of know-how and expertise. The company expects to complete its acquisition once closing conditions have been cleared.

Mid Atlantic Bio Angels (MABA) announced that Ultravision LLC was chosen as "Best in Show" at MABA's New Jersey 1st Pitch Life Science event. The event took place at the Institute for Life Science Entrepreneurship on the campus of Kean University in Union, New Jersey, on May 6, 2015. Ultravision is a medical device company that has developed a unique ultrasound needle that allows physicians to perform peripheral nerve blocks for pain management while using color to identify their location.

MedQuest Radiology Management Services has found that maintaining a focus on data can increase radiology sales and marketing success, resulting in a significant boost to revenues and the bottom line. This is a more sustainable solution than the more common reaction of cutting overhead when radiology departments and centers start feeling the pinch from decreasing reimbursement and rising costs.

Three new studies evaluating the primary care trends in prostate cancer screening were presented during the 110th Annual Scientific Meeting of the American Urological Association (AUA) in New Orleans. The research was highlighted by study authors during a special press conference. Sam Chang, M.D., AUA spokesperson and professor of Urology at Vanderbilt University Medical Center, moderated the session.

According to a new study, small changes in quality improvement procedures enabled clinicians to use magnetic resonance imaging (MRI) scans to diagnose stroke patients before giving acute treatment, within 60 minutes of arrival. MRI scans provide detailed images but take longer to complete than computed tomography (CT) scans, which are commonly used in most centers.

Holographic Optical Technologies has made its Voxgram hologram technology available to the consumer market through its just-launched Kickstarter campaign.

Fluke Biomedical launched Advantage Training, an online center aimed at providing accessible training to the biomedical engineering community.

Five new studies evaluating the use of imaging and urine-based biomarkers as ways to improve prostate cancer detection will be presented during the 110th annual scientific meeting of the American Urological Association (AUA). The research will be highlighted by study authors during a special press conference. Scott Eggener, M.D., AUA spokesperson and associate professor of surgery for urologic oncology at the University of Chicago Medicine, will moderate the session.